High Density Lipoprotein Cholesterol and Apoprotein A1 in Healthy Volunteers during Long-Term Moderate Alcohol Intake

1984 ◽  
Vol 28 (6) ◽  
pp. 377-384 ◽  
Author(s):  
P. Couzigou ◽  
B. Fleury ◽  
R. Crockett ◽  
J.J. Rautou ◽  
P. Blanchard ◽  
...  
Keyword(s):  
High Density Lipoprotein ◽  
Healthy Volunteers ◽  
High Density Lipoprotein Cholesterol ◽  
Alcohol Intake ◽  
Density Lipoprotein ◽  
High Density ◽  
Lipoprotein Cholesterol ◽  
Apoprotein A1 ◽  
Moderate Alcohol Intake

scholarly journals Long-Term Increase in Cholesterol Is Associated With Better Cognitive Function: Evidence From a Longitudinal Study

2021 ◽  
Vol 13 ◽  
Author(s):  
Huamin Liu ◽  
Lianwu Zou ◽  
Rui Zhou ◽  
Minyi Zhang ◽  
Shanyuan Gu ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Cognitive Function ◽  
High Density Lipoprotein ◽  
Cognitive Decline ◽  
High Density Lipoprotein Cholesterol ◽  
Memory Function ◽  
Density Lipoprotein ◽  
High Density ◽  
Lipoprotein Cholesterol

Background: Higher visit-to-visit cholesterol has been associated with cognitive decline. However, the association between long-term increase or decrease in cholesterol and cognitive decline remains unclear.Methods: A total of 4,915 participants aged ≥45 years with normal cognition in baseline were included. The participants were divided into four groups, namely low–low, low–high, high–low, and high–high, according to the diagnostic thresholds of total cholesterol (TC), non-high-density lipoprotein cholesterol (NHDL-C), low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol (HDL-C) after 4 years of follow-up. Cognitive function was assessed by episodic memory and mental intactness. Binary logistic regression was used to analyse the association of cholesterol variation with cognitive decline.Results: Among the participants, 979 (19.9%) experienced global cognitive decline. The odds ratio (OR) of global cognitive and memory function decline were remarkably lower in participants in the low–high NHDL-C group than those in the low–low group [OR and 95% confidence interval (CI): 0.50 [0.26–0.95] for global cognitive decline, 0.45 [0.25–0.82] for memory function decline]. The lower OR was also significant in females (OR [95% CI]: 0.38 [0.17–0.87] for global cognitive decline; 0.44 [0.19–0.97] for memory function decline) and participants without cardiovascular disease (OR [95% CI]: 0.31 [0.11–0.87] for global cognitive decline; 0.34 [0.14–0.83] for memory function decline). The increases in other cholesterol were also negatively associated with the risk of cognitive decline although not significantly.Conclusions: A longitudinal increase in NHDL-C may be protective for cognition in females or individuals without cardiovascular disease.

Sign in / Sign up

Export Citation Format

Share Document